UK Biobank

GlaxoSmithKline, Regeneron partner to generate genetic sequence data

Thursday, March 23, 2017

Regeneron Pharmaceuticals has announced a major research initiative among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK to generate genetic sequence data from the 500,000 volunteer participants in the U.K. Biobank resource. The initiative will enable researchers to gain valuable insights to support advances in the development of new medicines for a wide range of serious and life threatening diseases.

[Read More]